| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/25/2005 | DE19540233B4 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 08/25/2005 | DE10293600B4 Transdermal patch for treating nicotine addiction by blocking acetylcholine and noradrenaline release comprises clonidine or a combination of atropine and scopolamine |
| 08/25/2005 | DE102004007032A1 Antisense oligonucleotides hybridizing with mRNA or a gene sequence to code structures inhibiting skin or hair pigmentation act in melanine synthesis, expression of melanosome structures and/or melanosome transfer |
| 08/25/2005 | DE102004006829A1 Cosmetic composition for e.g. preventing or treating acne or sebum production contains actives combination of isoflavones and antiperspirants |
| 08/25/2005 | DE102004006144A1 Formulierungshilfsmittel Formulation auxiliaries |
| 08/25/2005 | DE102004006115A1 Verfahren zur Herstellung von monodispersen acrylhaltigen Perlpolymerisaten Process for the preparation of monodisperse bead polymers containing acrylic |
| 08/25/2005 | DE102004006106A1 Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinolde A process for producing dry powders of one or more Carotinolde |
| 08/25/2005 | DE102004004901A1 Verfahren zur Herstellung von Sorbicillacton A A process for the preparation of sorbicillacton |
| 08/25/2005 | CA2566315A1 Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumour cells |
| 08/25/2005 | CA2556601A1 The use of o-atp for the treatment of diseases involving angiogenesis |
| 08/25/2005 | CA2556568A1 Substituted pyrazoline compounds for reducing triglycerides in blood |
| 08/25/2005 | CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556478A1 Pyrazoline derivatives useful for the treatment of cancer |
| 08/25/2005 | CA2556405A1 Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/25/2005 | CA2556400A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556398A1 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 08/25/2005 | CA2556256A1 Method and compositions for treatment of painful disorders |
| 08/25/2005 | CA2556254A1 Aqueous solution preparation containing camptothecins |
| 08/25/2005 | CA2556239A1 Vanilloid receptor ligands and their use in treatments |
| 08/25/2005 | CA2556220A1 Chronotherapeutic compositions and methods of their use |
| 08/25/2005 | CA2556159A1 Methods of modulating neurotrophin-mediated activity |
| 08/25/2005 | CA2556106A1 Modafinil compositions |
| 08/25/2005 | CA2556096A1 Use of acrylic-acid based polymers to treat and prevent inflammatory skin conditions |
| 08/25/2005 | CA2556089A1 Method for enhancing the bioavailability of ospemifene |
| 08/25/2005 | CA2556086A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
| 08/25/2005 | CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| 08/25/2005 | CA2556069A1 Compounds having antitumor activity |
| 08/25/2005 | CA2555882A1 Controlled release formulations |
| 08/25/2005 | CA2555827A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 08/25/2005 | CA2555825A1 Process for the preparation of substituted triazole compounds |
| 08/25/2005 | CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 08/25/2005 | CA2555815A1 Dihydrotetrabenazines and pharmaceutical compositions containing them |
| 08/25/2005 | CA2555811A1 Methods for treating resistant or refractory tumors |
| 08/25/2005 | CA2555789A1 Ctgf as target for the therapy of diabetic nephropathy |
| 08/25/2005 | CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 08/25/2005 | CA2555675A1 Nicotinamide riboside kinase compositions and methods for using the same |
| 08/25/2005 | CA2555594A1 Pyridazinones as antagonists of a4 integrins |
| 08/25/2005 | CA2555507A1 Use of proton pump inhibitors for the treatment of cancer conditions |
| 08/25/2005 | CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | CA2555365A1 Methods and compositions for treating tumors and metastatic disease |
| 08/25/2005 | CA2555319A1 Inhibiting cav3 isoforms and the .delta.25b splice variants for the diagnosis and treatment of cancer |
| 08/25/2005 | CA2555294A1 Candesartan cilexetil polymorphs |
| 08/25/2005 | CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators |
| 08/25/2005 | CA2555248A1 Use of 2,5 dihydroxybenzenesulfonic acid, in the manufacturing of medicines, applicable to the treatment of angiodependent diseases |
| 08/25/2005 | CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins |
| 08/25/2005 | CA2555176A1 Hiv integrase inhibitors |
| 08/25/2005 | CA2555149A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
| 08/25/2005 | CA2555145A1 Diagnosis and therapeutics for cancer |
| 08/25/2005 | CA2555142A1 Cell proliferation associated with ccx ckr expression |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/25/2005 | CA2555099A1 Alcohol metabolism moderating composition |
| 08/25/2005 | CA2554996A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases |
| 08/25/2005 | CA2554974A1 Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma |
| 08/25/2005 | CA2554971A1 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 08/25/2005 | CA2554748A1 External preparation for treating painful skin wound |
| 08/25/2005 | CA2554559A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 08/25/2005 | CA2554465A1 Piperidine derivatives useful as ccr3 antagonists |
| 08/25/2005 | CA2554463A1 Anti-cancer therapies |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/25/2005 | CA2554271A1 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| 08/25/2005 | CA2554212A1 Rna interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional sina) |
| 08/25/2005 | CA2554099A1 Glycine and/or for use in cartilage affecting conditions |
| 08/25/2005 | CA2553889A1 7h-pyrrolopyrimidine derivatives |
| 08/25/2005 | CA2553748A1 Composition and method for use in cartilage affecting conditions |
| 08/25/2005 | CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 08/25/2005 | CA2553442A1 Compounds and compositions as lxr modulators |
| 08/25/2005 | CA2552871A1 Novel, sustained-action beta-2-agonists and their use as medicaments |
| 08/25/2005 | CA2552843A1 Steroids for cancer treatment |
| 08/25/2005 | CA2549954A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/25/2005 | CA2549432A1 Lipid rafts and clostridial toxins |
| 08/25/2005 | CA2536622A1 Inhibitors of cellular necrosis |
| 08/24/2005 | EP1566636A1 Use of Tweak modulators and inhibitors for the treatment of neurological conditions |
| 08/24/2005 | EP1566446A1 beta-1,4-MANNOBIOSE-CONTAINING COMPOSITION |
| 08/24/2005 | EP1566439A1 Preventing or treating obesity |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566380A1 Isoquinoline compounds and medicinal use thereof |
| 08/24/2005 | EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 08/24/2005 | EP1566202A1 Use of resistin antagonists in the treatment of rheumatoid arthritis |
| 08/24/2005 | EP1566187A2 Polyacrylates coating for implantable medical devices |
| 08/24/2005 | EP1566184A1 Remedy for corneal failure |
| 08/24/2005 | EP1566182A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 08/24/2005 | EP1566177A1 The use of bisphosphonates for treating skin by stimulating of collagen synthesis |
| 08/24/2005 | EP1566176A1 Synergistic antibacterial formulation and a method of making the same |
| 08/24/2005 | EP1566175A1 Topical preparation comprising at least one aryloxime and bisabolol |
| 08/24/2005 | EP1566174A2 Flash-melt oral dosage formulation |
| 08/24/2005 | EP1566173A1 Pharmaceutical composition for oral application and method for preparing thereof |
| 08/24/2005 | EP1565866A1 System and method for generating an amalgamated database |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565481A1 Antiviral nucleoside derivatives |
| 08/24/2005 | EP1565478A2 Polysaccharide vaccine for staphylococcal infections |
| 08/24/2005 | EP1565471A1 Quinolinyl-pyrrolopyrazoles |
| 08/24/2005 | EP1565464A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 08/24/2005 | EP1565458A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 08/24/2005 | EP1565456A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/24/2005 | EP1565453A1 2- (4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists |
| 08/24/2005 | EP1565451A1 Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| 08/24/2005 | EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |